Bioorganic and Medicinal Chemistry Letters p. 307 - 310 (1996)
Update date:2022-08-05
Topics:
Rivero
Kevin
Kivlighn
Zingaro
Chang
Greenlee
Simple modifications made to our potent angiotensin II AT1 selective clinical candidate MK-996 provided a compound with balanced binding affinity to both the AT1 and the AT2 receptor subtype. This compound, L-162,389 is or
View MoreWuxi Zuping Food Science And Technology Co.,LTD.
Contact:+86-510-87210822
Address:Guanlin town
jiangsu hualin chemical co.,ltd.
Contact:86-25-87787402
Address:jaingsu,china
Jiangxi Lanqi Fine Chemical S&T Co., Ltd.
Contact:+86-21-64891143
Address:XinJiShan Industrial Area, Zhangshu City, JiangXi Province, China
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Doi:10.1016/j.tet.2016.01.021
(2016)Doi:10.1021/ol025627w
(2002)Doi:10.1016/S0040-4039(97)01728-0
(1997)Doi:10.1021/om400452q
(2013)Doi:10.1021/jo00058a005
(1993)Doi:10.1107/S010827019600491X
(1996)
